Studies offer new treatment option to prevent kidney rejection

October 29, 2002

PHILADELPHIA - A new study of the most commonly prescribed post-kidney transplant drug suggests it may not be the most effective weapon to fend off organ rejection and may even damage some donor kidneys. The research, to be presented Nov. 2 at the American Society of Nephrology annual meeting, identified another drug that seems to work better, a finding that could help expand the pool of donor organs.

An analysis by an Ohio University physiologist suggests that large doses of cyclosporine, the most often used anti-rejection drug, could cause a drop in the rate at which the kidney filters blood and decrease blood flow to the kidney. For patients who receive what's known as a "marginal kidney," problems with cyclosporine may be particularly dangerous, the study found. A shortage of donor kidneys has prompted doctors to consider the use of organs from people who had high blood pressure or other health problems, as well as donor kidneys from non-heart beating donors. These marginal kidneys once were presumed to have higher failures rates, but research now suggests that the majority of them fare as well as any other transplanted organ. But such kidneys may be more prone to ischemia-reperfusion injury, tissue damage that occurs when blood flow to an organ is stopped, then started again after a period of time. The injury is common in all kidney transplants, but may be particularly severe in patients who receive marginal kidneys.

"More hospitals are starting to use marginal kidneys more often," said Sharon Inman, lead author of the study and assistant professor of biomedical sciences in the university's College of Osteopathic Medicine. "We want to see if we can make those kidneys exposed to ischemia-reperfusion injury work better so we can use them for transplant."

Inman is studying the effectiveness of rapamycin, a new immunosuppressant that controls the immune system differently than its more widely used counterpart and, according to Inman's preliminary findings from a study in rats, may do so without harming the kidney.

"The kidneys treated with cyclosporine fared much worse that those treated with rapamycin," Inman said, adding that those organs suffered more restricted blood flow and poorer kidney filtration. This study followed the rats for five to seven days; the next step in the project is to follow them for a longer period of time. Inman also is interested in studies that suggest certain cholesterol-lowering drugs may improve renal function, and is launching another project to see if cholesterol medication can counteract the negative effect cyclosporine can have on the kidneys.

Last year, 14,152 people in the United States received a donor kidney, according to the United Network for Organ Sharing. But more than four times that number ended the year on the national organ transplant waiting list and another 2,861 died before a match could be found.

The use of marginal kidneys as a donor alternative may be more common today, but they still accounted for less than 2 percent of all organ transplants in 1999, the most recent year for which UNOS has data.

And the practice is not without controversy. Some of those kidneys come from non-heart beating donors - patients who, although they are not brain dead, could not survive without life-support equipment. Some claim this encourages the premature ending of the life of the donor. Others point to the two criteria used by many doctors for determining death: heart oriented and brain oriented. Scientists and physicians are now pushing for a uniform policy written by non-transplant specialists that would be instituted at all transplant centers.

"It's crucial that the public is aware and understands the endpoint of death," Inman said. "This is important since 'marginal' organs, such as those retrieved from non-heart beating donors, could expand the donor pool."

Inman's studies are supported by a National Kidney Foundation Young Investigator Grant. The research was co-authored by Nancy Davis, a research technician, and Kristen Olson and Vicky Lukaszek, juniors in pre-med studies, all at Ohio University.
-end-
Written by Kelli Whitlock.

Ohio University

Related Blood Flow Articles from Brightsurf:

Brain regions with impaired blood flow have higher tau levels
In Alzheimer's disease, impaired blood flow to brain regions coincides with tau protein buildup.

3D ultrasound enables accurate, noninvasive measurements of blood flow
A 3D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a new study.

Blood flow recovers faster than brain in micro strokes
Work by a Rice neurobiologist shows that increased blood flow to the brain is not an accurate indicator of neuronal recovery after a microscopic stroke.

Exercise improves memory, boosts blood flow to brain
Scientists have collected plenty of evidence linking exercise to brain health, with some research suggesting fitness may even improve memory.

3D VR blood flow to improve cardiovascular care
Biomedical engineers are developing a massive fluid dynamics simulator that can model blood flow through the full human arterial system at subcellular resolution.

MRI shows blood flow differs in men and women
Healthy men and women have different blood flow characteristics in their hearts, according to a new study.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Blood flow monitor could save lives
A tiny fibre-optic sensor has the potential to save lives in open heart surgery, and even during surgery on pre-term babies.

Changes in blood flow tell heart cells to regenerate
Altered blood flow resulting from heart injury switches on a communication cascade that reprograms heart cells and leads to heart regeneration in zebrafish.

Blood flow command center discovered in the brain
An international team of researchers has discovered a group of cells in the brain that may function as a 'master-controller' for the cardiovascular system, orchestrating the control of blood flow to different parts of the body.

Read More: Blood Flow News and Blood Flow Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.